FireFly Metals Ltd has appointed highly experienced Jessie Liu-Ernsting as chief corporate development officer, further strengthening its executive team as it advances its Green Bay Copper-Gold Project in Canada.
Read more: FireFly Metals launches major drill push at fully funded Green Bay copper-gold mine
Race Oncology Ltd has opened patient enrolment at a second site for its RC220 Phase 1 Solid Tumour Clinical Trial.
The study has been designed to allow the company to glean human safety and pharmacokinetic statistics, identify the maximum tolerated combined dose of RC220 and doxorubicin and provide a first glimpse of clinical data on the cardioprotective, anticancer and m6A RNA activities of RC220.
Reconnaissance Energy Africa Ltd (TSX-V:RECO, OTCQX:RECAF) (ReconAfrica) is set to unlock considerable hydrocarbon potential, analysts say, following its move into Angola announced last week.
The Canadian company signed an agreement with Angola’s national oil regulator, Angola’s National Agency for Petroleum, Gas, and Biofuels (ANPG), granting ReconAfrica 5.2 million net acres of onshore exploration rights in southeastern Angola’s Etosha-Okavango basin.
Spanish Mountain Gold Ltd (TSX-V:SPA, OTC:SPAZF) on Monday reported encouraging near-surface and high-grade gold intercepts from its 2025 winter drill program, highlighting multiple mineralized zones across key targets at its project in British Columbia’s Cariboo Gold Corridor.
The drilling aims to expand the current resource beyond the 2021 pit-constrained estimate and accelerate the project toward a construction decision by 2027.
Lumina Gold Corp (TSX-V:LUM, OTCQB:LMGDF) announced on Monday that it has agreed to be acquired by CMOC Singapore, a subsidiary of CMOC Group Ltd, in an all-cash deal worth approximately C$581 million.
Under the terms of the arrangement, CMOC will acquire all issued and outstanding shares of Lumina at C$1.27 per share, representing a 71% premium to Lumina’s 20-day volume weighted average trading price and a 41% premium to the company’s closing price on April 17.
Medicus Pharma (NASDAQ:MDCX) said it has received approval from an Institutional Review Board (IRB) to increase the number of participants in its ongoing Phase 2 clinical trial of a novel non-invasive treatment for basal cell carcinoma (BCC), the most common form of skin cancer.
The company will raise the trial's enrollment target to 90 patients from 60 and expand the study beyond the current nine clinical sites in the United States to additional US locations and two in Europe.
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) CEO Dr Eric Leire talked with Proactive about the company’s new strategic partnership with US-based Heureka Labs, a spinoff of Duke University, to enhance its gene therapy research using AI technology.
Leire said, “Every biotech in gene therapy should have an AI component. If you don't have that, you miss a critical tool to unlock value for your shareholders.” He stressed the need for a multi-omics approach—genomic, transcriptomic, and proteomic—to better understand gene expression and drug response, which traditional analysis methods struggle to fully capture.
HIVE Digital Technologies (TSX-V:HIVE, NASDAQ:HIVE) has flipped the switch on Phase 1 of its new data centre in Paraguay, marking a big step in its plans to boost bitcoin mining capacity.
The Canadian tech company said it had finished building and energising the first 100 megawatts of infrastructure at its Yguazù site – enough to eventually support 5 exahash per second (EH/s) of mining power.